Dr. Neil B. Friedman, MD

Dr. Friedman practices at Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center.

Dr. Friedman's NPI, 1538103676, was assigned on June 16, 2006. Dr. Friedman graduated from University of Maryland School of Medicine in 1983. Dr. Friedman holds Maryland license D38034.

Dr. Friedman's primary practice is Mercy Medical Center, at 301 Saint Paul Place, Baltimore, MD 21202 in Baltimore City. The practice phone is (410) 332-9237.

Dr. Friedman's primary practice is Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center. The medical group on file is Mercy Personal Physicians Downtown. Dmand AI also links Dr. Friedman to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Friedman is licensed in Maryland.

CMS data shows 770 Medicare services from Dr. Friedman across 12 procedure codes in 2024, for 515 Medicare patients. Medicare paid $96,434 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 515 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 276 patients. 75% of them have cancer, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 71, with 99% women.

In 2024, Dr. Friedman wrote 55 Medicare Part D claims for 24 patients. 93% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $1,393 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Friedman for performance year 2024, reported as part of a group. Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 86 procedures of mastectomy by Dr. Friedman, more than 98% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Friedman, published from 2016 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Black or African American and Intraoperative Care. Dr. Friedman's most frequent co-authors are Emily Jane Gallagher, BAO, BCH, MB, Tari A. King, MD and Shawna C. Willey, MD.

Dmand AI links Dr. Friedman to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 23 general payments to Dr. Friedman from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. AxoGen paid the most, $1,248.

Dr. Friedman graduated from University of Maryland School of Medicine in 1983.